PRINCETON N.J. Feb. 21 2012 PRNewswire &160;Soligenix Inc. OTCBB SNGXD Soligenix or the Company a development stage biopharmaceutical company announced today further promising preliminary results from its continuing preclinical study of SGX202 oral bec...
↧